Beacon Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	187.82	306.95	452.19	538.5	337.84	598.78
Short-Term Investments	3,374	15.36	26.33	6.16	5.87	14.67
Cash & Short-Term Investments	3,562	322.32	478.52	544.66	343.71	613.45
Cash Growth	232.03%	-32.64%	-12.14%	58.46%	-43.97%	106.90%
Accounts Receivable	2,980	2,758	2,081	1,964	1,933	1,060
Other Receivables	-	224.79	134.55	-	-	168.99
Receivables	2,980	5,610	4,947	2,486	2,337	1,229
Inventory	2,606	2,888	1,992	1,972	1,279	1,033
Other Current Assets	4,652	3,897	1,566	1,301	1,016	605.59
Total Current Assets	13,799	12,717	8,983	6,444	5,216	3,786
Property, Plant & Equipment	6,050	6,187	5,648	4,371	3,319	3,391
Long-Term Investments	-	-	-	1.03	0.87	0.63
Other Intangible Assets	21.13	27.98	10.79	-	-	-
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	19,870	18,932	14,642	10,816	8,536	7,177
Accounts Payable	2,117	905.7	297.45	32.51	113.67	-27.09
Accrued Expenses	-	310.19	209.52	448.83	354.26	232.32
Short-Term Debt	6,126	6,699	6,500	3,413	1,884	1,535
Current Portion of Long-Term Debt	935.04	891.43	182.55	216.01	225.9	153.89
Current Income Taxes Payable	491.06	246.13	79.54	258.59	-18.65	-
Other Current Liabilities	28.01	209.71	220.88	305.13	233.92	159.91
Total Current Liabilities	9,697	9,262	7,490	4,674	2,793	2,054
Long-Term Debt	3,006	2,729	772.48	197.91	387.75	493.02
Pension & Post-Retirement Benefits	516.34	673.74	323.95	-	-	-
Long-Term Deferred Tax Liabilities	128.91	176.57	113.44	-	-	-
Total Liabilities	13,349	12,841	8,700	4,872	3,180	2,547
Common Stock	2,310	2,310	2,310	2,310	2,310	2,310
Retained Earnings	3,411	2,892	2,565	2,404	1,639	738.74
Comprehensive Income & Other	800.27	888.6	1,067	1,229	1,406	1,582
Shareholders' Equity	6,522	6,090	5,942	5,944	5,355	4,630
Total Liabilities & Equity	19,870	18,932	14,642	10,816	8,536	7,177
Total Debt	10,067	10,319	7,455	3,827	2,497	2,181
Net Cash (Debt)	-6,505	-9,997	-6,977	-3,282	-2,153	-1,568
Net Cash Per Share	-28.16	-43.28	-30.20	-14.21	-9.32	-6.79
Filing Date Shares Outstanding	231	231	231	231	231	231
Total Common Shares Outstanding	231	231	231	231	231	231
Working Capital	4,102	3,455	1,493	1,770	2,423	1,732
Book Value Per Share	28.23	26.37	25.72	25.73	23.18	20.04
Tangible Book Value	6,501	6,062	5,931	5,944	5,355	4,630
Tangible Book Value Per Share	28.14	26.24	25.68	25.73	23.18	20.04
Land	-	663.81	657.98	624.1	566.06	566.06
Buildings	-	2,208	1,083	978.41	978.41	978.41
Machinery	-	4,745	4,014	3,031	2,465	2,270
Construction In Progress	-	1,130	1,957	1,299	437.22	342.81

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.